Companies

Granza Bio

granzabio.com

Reprogramming Immunity for Target-Specific Medicines

HQSan Francisco, CA, USA
Employees1-50

About

Granza Bio is building on the discovery of a previously unknown cytotoxic mechanism in T cells: supramolecular attack particles (SMAPs, Science 2020). This biology reveals a new modality through which cytotoxic lymphocytes deliver persistent, high-intensity killing.

Active Roles

0

No active roles right now.

Get notified when they post